Swiss Parliament has approved two new exceptions to the effects of a patent, namely:
- the prescription of medicines by medical personnel in individual cases;
- the direct preparation of individual medicines in pharmacies.
At the beginning of 2010, the European Patent Office changed its case law allowing patents to have broader rights in future to additional medical indications. The Federal Supreme Court maintained that the freedom of physicians to prescribe or dispense generic medicines may be restricted under this new case law.
To resolve the issue, Swiss Parliament decided:
- to exclude the prescription or use of medicines that relate to an individual person from the effects of a patent. This exception does not include non-specific series’ of treatments undertaken by medical personnel.
- to authorise pharmacies to prepare ready-made medicines containing prepared active ingredients and additives or medicinal substances for individual patients on the basis of medical treatment advised by a physician. This exception does not include the preparation of medication for keeping in stock, contract manufacturing or the manufacture of active ingredients.
This amendement to the patent law is a result of the ongoing revision of the Therapeutic Products Act. However, the date of its entry into force has not yet been determined.
Visit us from 26 to 29 September 2018 in Berlin at the Annual Conference of the German Association for the Protection of Intellectual Property (GRUR)
Pilot project for a collaboration of the five largest patent offices with search and examination of Patent Cooperation Treaty applications
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office